-
-
Dengue Vectors
Takeda5 minutes -
Vector control
Takeda4 minutes -
Surveillance and Reporting
Takeda5 minutes -
Economic Impact of Dengue
Takeda4 minutes -
Dengue global epidemiology
Takeda4 minutes -
Dengue Phases & Guidelines
Takeda4 minutes -
Antibody Levels over Time
Takeda2 minutes -
Dengue infection cycle and clinical spectrum
Takeda2 minutes -
Laboratory diagnostic tests
Takeda -
Case presentations in severe dengue: contemporary approaches to clinical management
Medscape45 minutes -
Differential diagnosis
Takeda1 minutes -
Management of cases
Takeda1 minutes -
Dengue disease states
Takeda4 minutes -
Mechanisms of dengue
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Immune response to dengue virus
Takeda4 minutes -
Dengue virus and pathobiology
Takeda1 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Clinical diagnosis and management of dengue
PAHO -
Randomised trials of Wolbachia for dengue control – a step towards elimination?
ADVA50 minutes -
Impact of the COVID-19 Pandemic on the Global Dengue Situation
ADVA79 minutes -
Dengue Clinical Case Management
CDC -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Dengue diagnosis: unique challenges in a time of a pandemic
Medscape15 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021